Insider · CIK 0001415537

Mark T Iwicki

Files at: QTTB, KALA, PULM, AIMT. On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $620k · 2sales $0 · 0net $620k

Reported trades — common stock

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
May 23, 2018 AForm 4 →	May 24, 5:06 pm EDT	Aimmune Therapeutics, Inc.AIMT	3,750	—	—	33,125	—	plan?
Apr 3, 2018 PForm 4 →	Apr 5, 8:07 pm EDT	Pulmatrix, Inc.PULM	307,000	—	—	307,000	—	plan?
Feb 26, 2018 PForm 4 →	Feb 26, 4:05 pm EST	Aimmune Therapeutics, Inc.AIMT	9,375	$32.00	$300,000	29,375	+46.9%	plan?
Aug 11, 2015 PForm 4 →	Aug 11, 11:40 am EDT	Aimmune Therapeutics, Inc.AIMT	20,000	$16.00	$320,000	20,000	—	plan?

Reported trades — derivatives (options, RSUs, warrants)

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
Jun 12, 2026 AForm 4/A →	Jul 21, 8:37 pm EDT	Q32 Bio Inc.QTTB	10,826	—	—	10,826	—
Jun 12, 2026 AForm 4 →	Jun 16, 4:30 pm EDT	Q32 Bio Inc.QTTB	9,810	—	—	9,810	—	amended
Jan 2, 2019 AForm 4 →	Jan 4, 5:05 pm EST	Kala Pharmaceuticals, Inc.KALA	460,000	—	—	460,000	—
Jun 5, 2018 AForm 4 →	Jun 6, 6:02 pm EDT	Pulmatrix, Inc.PULM	155,000	—	—	155,000	—
May 23, 2018 AForm 4 →	May 24, 5:06 pm EDT	Aimmune Therapeutics, Inc.AIMT	7,500	—	—	7,500	—
Apr 3, 2018 PForm 4 →	Apr 5, 8:07 pm EDT	Pulmatrix, Inc.PULM	614,000	—	—	307,000	—
Feb 7, 2018 AForm 4 →	Feb 9, 4:32 pm EST	Kala Pharmaceuticals, Inc.KALA	230,000	—	—	230,000	—
Jul 19, 2017 AForm 4 →	Jul 21, 4:22 pm EDT	Kala Pharmaceuticals, Inc.KALA	78,632	—	—	78,632	—
May 25, 2017 AForm 4 →	May 30, 4:05 pm EDT	Aimmune Therapeutics, Inc.AIMT	17,500	—	—	17,500	—
Mar 20, 2017 AForm 4 →	Mar 22, 6:54 pm EDT	Pulmatrix, Inc.PULM	4,400	—	—	4,400	—
May 25, 2016 AForm 4 →	May 27, 4:06 pm EDT	Aimmune Therapeutics, Inc.AIMT	19,755	—	—	19,755	—
Dec 8, 2015 AForm 4 →	Dec 9, 10:40 am EST	Pulmatrix, Inc.PULM	73,481	—	—	73,481	—